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hospital stay was higher in HOSP2 (11.3 vs. 14.5, p < 0.01). Sig-
niﬁcant differences were anyway conﬁrmed only among non
infected patients. Our results were not conﬁrmed with the boot-
strap method. CONCLUSIONS: Cost of antibiotic therapy, its
effects on the risk of infections and length of remission can be
inﬂuenced by the therapeutic choices. Information on potential
consequences is useful to implement optimal therapeutic
approaches.
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OBJECTIVES: The aim of this study to calculate the health
insurance cost of treatment of patients with peritrochanter frac-
ture of femur from the ﬁrst hospital admission for 18 months
follow up period according to most frequently used 4 different
surgical methods (ender nailing, ﬁx angled plate, gamma nailing
and dynamic hip screw ﬁxation (DHS). METHODS: Recruit-
ment criteria were: 1) all patients with a hip fracture in 2000
deﬁned by the International Classiﬁcation of Disease (ICD) as
“S7210”; 2)working age between 18–65; 3) ﬁrst admission to
surgical unit, and had an operation because of monotraumatic
peritrochanteric fracture of femur; and 4) without comorbidities.
The cost analysis includes the cost of acute and chronic in-patient
care, outpatient care and sick pay. RESULTS: The total number
of patients having peritrochanteric fracture of the femur was
1154. Due to the inclusion criteria listed in the data and methods
chapter altogether 186 patients were included into the study. The
total costs were the highest in case of those types of operations
with lower cost of prosthesis device and lower load stability:
Ender nailing €2322, ﬁx angled plate €2109 because of the
higher sick-pay costs. The total costs were the lowest in case of
those types of operations with higher cost of prosthesis device
and higher load stability (Gamma nailing €2022, dynamic hip
screw €1836) because of the lower sick-pay costs. The average
days spent on sickness-pay varied according to the types of sur-
gical methods. Gamma nailing-182 days, DHS ﬁxation-212
days, Ender nailing—310 days, ﬁx angled plate—269 days.
CONCLUSION: In case of surgical methods with lower com-
plication rate and quicker load stability (Gamma nailing, DHS
ﬁxation) the cost of primary treatment is higher but the total
costs are lower because of lower additional costs (chronic care,
sickness-pay).
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OBJECTIVE: The purpose of this study was to analyze blood
transfusion patterns and associated costs by various spinal
surgery subtypes in the US inpatient setting. METHODS: This
study used Premier’s US Inpatient Comparative Database, con-
taining approximately 5 million admissions annually, from over
500 hospitals. A total of 31,808 inpatient discharges with
primary procedure codes for spinal fusion surgery (ICD-9 codes
81.01–81.08, 81.31–81.38, 81.61; US projected total: 274,523)
between July 2003 and June 2004 were selected and stratiﬁed
into seven surgical subtypes based on the anatomic location of
fused vertebrae and surgical technique. Blood management pat-
terns were examined pre- and post-surgery. The association
between spinal surgery subtypes and blood transfusion costs
were examined using multivariate regression after controlling for
various patient-(age, race, gender, severity), hospital-(location,
teaching status, bedsize, region), and clinical-factors, inpatient
mortality, payer type (Medicare, Medicaid, commercial/managed
care), and physician specialty. RESULTS: Spinal fusion surgeries
incurred average (maximum) blood transfusion costs of
$149–$493 ($3,300–$13,120) per surgery, depending on
subtype. As compared to cervical fusions, dorsal/dorsolumbar
and lumbar/lumbosacral fusions as well as refusions were 
associated with signiﬁcantly higher blood transfusion costs
($100–$195; p < 0.0001). Being operated by a neurosurgeon was
associated with lower blood transfusion costs (p < 0.0001).
Blood transfusion costs increased with increasing patient sever-
ity ($967), hospital bedsize ($100–$142), and urban/teaching
status (p < 0.0001). Use of volume expanders and erythropoetic
agents signiﬁcantly increased blood transfusion costs by $184
and $294, respectively (p < 0.0001). Being male, discharged to
home, and the use of topical sealants, were associated with lower
total transfusion costs. CONCLUSIONS: This study demon-
strates that the anatomical location, surgical approach, physician
specialty, and hospital characteristics are all associated with
blood transfusion costs. Newer technologies/medications may
reduce blood transfusion use/costs, and this potential for reduc-
tion may be even greater in certain subgroups.
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OBJECTIVE: To analyze blood transfusion patterns and associ-
ated costs in hip/knee replacement and revision surgeries in the
US inpatient setting. METHODS: This study used Premier’s US
Inpatient Comparative Database, containing approximately 5
million discharges annually, from over 500 hospitals. A total of
12,211 inpatient discharges with a primary procedure for hip
(ICD-9 codes 81.51, 81.53; US projected total: 274,542 proce-
dures) and 17,805 for knee arthroplasty (ICD-9 codes 81.54,
81.55; US projected total: 494,629 procedures) between July
2003 and June 2004 were evaluated. Blood management pat-
terns were examined pre- and post-surgery. The association
between surgery subtypes and transfusion costs were examined
using multivariate regression after controlling for various
patient-(age, race, gender, severity), hospital-(location, teaching
status, bedsize, region), and clinical-factors, inpatient mortality,
payer type (Medicare, Medicaid, commercial/managed care), and
physician specialty. RESULTS: Average (maximum) blood trans-
fusion costs of $448 ($11,838), $720 ($27,957), $321
($17,328), and $427 ($5182) were incurred for total hip replace-
ment, hip revision, knee replacement, and knee revision, respec-
tively. Multivariate analyses showed that hip and knee revision
costs were $272 and $66 higher than hip replacement, respec-
tively (p < 0.0001). Being operated on by an orthopedic surgeon
was associated with slightly lower total transfusion costs (p <
0.0001). Blood transfusion costs increased with increasing sever-
ity ($1049; p < 0.001), comparing most severe to mild. Use of
hypotensive anesthesia and topical sealants were associated with
a $131 and $101 reduction, respectively, whereas the use of ery-
thropoetic agents was associated with a $210 increase in total
transfusion costs (p < 0.0001). Blood transfusion costs increased
